(NASDAQ:AMZN) Is Exploring The Use Of Giant Airships To Serve As Mobile, Flying Warehouses, Inc. (NASDAQ:AMZN) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -2.00% to $749.87. Amazon is exploring the use of giant airships to serve as mobile, flying warehouses that could help the online retail giant deliver more of its goods by drone. You might already be familiar with Amazon’s drone delivery service, which recently received a demo in the United Kingdom for the first time.

But the idea for a fleet of large airships, disclosed in filings to the US Patent and Trademark Office, expand on those ambitions dramatically. (Amazon chief executive Jeffrey P. Bezos also owns The Washington Post.) The share price of AMZN attracts active investors, as stock price of week volatility recorded 1.67%. The stock is going forward to its 52-week low with 58.20% and lagging behind from its 52-week high price with -11.49%.

HollyFrontier Corporation (NYSE:HFC) [Trend Analysis] moved down reacts as active mover, shares a loss -1.21% to traded at $32.76 and the percentage gap between open changing to regular change was -0.21%. HollyFrontier Corporation (HFC) recently reported that unplanned fourth quarter maintenance on its Navajo refinery Catalytic Reforming Unit (CRU) has been completed. Additionally, cold weather in December at Navajo resulted in boiler outages which affected refinery run rates. The Tulsa refinery also experienced rate reduction in December due to unplanned CRU issues.

During the downtime the Tulsa refinery expects to accelerate maintenance for the East Crude Unit and other units originally planned for later in 2017 and take the opportunity to upgrade catalyst in the CRU with the latest technology. As a result of the planned and unplanned maintenance, HollyFrontier expects crude oil throughput for the fourth quarter 2016 to average between 425,000 and 435,000 barrels per day.

The firm’s current ratio calculated as 2.10 for the most recent quarter. The firm past twelve months price to sales ratio was 0.55 and price to cash ratio remained 12.05. As far as the returns are concern, the return on equity was recorded as -6.00% and return on investment was 13.30% while its return on asset stayed at -3.40%. The firm has total debt to equity ratio measured as 0.36.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *